These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21849008)

  • 1. Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease.
    Weiss TW; Seljeflot I; Hjerkinn EM; Arnesen H
    Int J Clin Pract; 2011 Sep; 65(9):939-44. PubMed ID: 21849008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
    He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
    Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
    Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
    Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
    Fain JN
    Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epicardial adipose tissue is a source of inflammatory mediators.
    Mazurek T; Zhang L; Zalewski A; Mannion JD; Diehl JT; Arafat H; Sarov-Blat L; O'Brien S; Keiper EA; Johnson AG; Martin J; Goldstein BJ; Shi Y
    Circulation; 2003 Nov; 108(20):2460-6. PubMed ID: 14581396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
    Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
    Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance and adipose tissue gene expression in humans].
    Bastard JP
    Ann Biol Clin (Paris); 2004; 62(1):25-31. PubMed ID: 15047487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
    Odrowaz-Sypniewska G
    Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
    Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.
    Madec S; Chiarugi M; Santini E; Rossi C; Miccoli P; Ferrannini E; Solini A
    J Hypertens; 2010 Jul; 28(7):1459-65. PubMed ID: 20589975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.
    Cheng X; Zhou Q; Lin S; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1048-56. PubMed ID: 21051829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
    Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher RM; Yki-Järvinen H
    Int J Obes (Lond); 2007 Oct; 31(10):1617-25. PubMed ID: 17452990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen.
    He G; Pedersen SB; Bruun JM; Richelsen B
    Horm Metab Res; 2000; 32(11-12):515-20. PubMed ID: 11246818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.
    Chen F; Eriksson P; Hansson GK; Herzfeld I; Klein M; Hansson LO; Valen G
    Int J Mol Med; 2005 Jan; 15(1):57-65. PubMed ID: 15583828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.